HEMOSTASIS
Total Payments
$300,023
Transactions
19
Doctors
0
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $79,962 | 18 | 0 |
| 2017 | $220,061 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $220,061 | 1 | 73.3% |
| Charitable Contribution | $79,962 | 18 | 26.7% |
Payments by Type
Research
$220,061
1 transactions
General
$79,962
18 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial | Boston Scientific Corporation | $220,061 | 0 |
Top Doctors Receiving Payments for HEMOSTASIS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | White River Junction, VT | $300,023 | 19 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $220,061
- Cook Incorporated $79,962
Product Information
- Type Device
- Total Payments $300,023
- Total Doctors 0
- Transactions 19
About HEMOSTASIS
HEMOSTASIS is a device associated with $300,023 in payments to 0 healthcare providers, recorded across 19 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2017 to 2018. In 2018, $79,962 was paid across 18 transactions to 0 doctors.
The most common payment nature for HEMOSTASIS is "Unspecified" ($220,061, 73.3% of total).
HEMOSTASIS is associated with 1 research study, including "Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial" ($220,061).